Marissa Brittenham
Chief Strategy Officer · Surgery Partners, Inc.
- 2026
- Mar 16, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Marissa Brittenham files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason Eric Evans - $412K in SGRY purchases and sales in the last 12 months
- David T. Doherty - $313K in SGRY purchases and sales in the last 12 months
- Teresa Deluca - $305K in SGRY purchases and sales in the last 12 months
- Jennifer Baldock - $214K in SGRY purchases and sales in the last 12 months
- Danielle Burkhalter - $150K in SGRY purchases and sales in the last 12 months
- William Trenton Webb - $29K in SGRY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Marissa Brittenham?
Marissa Brittenham is a corporate insider, tracked as Chief Strategy Officer of Surgery Partners, Inc. (SGRY). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Marissa Brittenham last file a Form 4?
The most recent primary Form 4 on record is dated 16 March 2026, one of 2 filings going back to 2026.
Has Marissa Brittenham been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($166K) across all tracked filings.
